ICMBX
Price
$13.72
Change
+$0.06 (+0.44%)
Updated
Oct 17 closing price
Net Assets
103.03M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

ICMBX vs RLBCX

Header iconICMBX vs RLBCX Comparison
Open Charts ICMBX vs RLBCXBanner chart's image
Intrepid Capital Investor
Price$13.72
Change+$0.06 (+0.44%)
VolumeN/A
Net Assets103.03M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
ICMBX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
ICMBX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICMBX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 266B vs. ICMBX (103M). ICMBX pays higher dividends than RLBCX: ICMBX (2.19) vs RLBCX (1.49). ICMBX was incepted earlier than RLBCX: ICMBX (21 years) vs RLBCX (23 years). ICMBX (1.93) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. ICMBX (33.00). RLBCX has a lower initial minimum investment than ICMBX: RLBCX (250) vs ICMBX (2500). ICMBX annual gain was more profitable for investors over the last year : 14.10 vs. RLBCX (8.34). ICMBX return over 5 years is better than : 59.95 vs. RLBCX (40.24).
ICMBXRLBCXICMBX / RLBCX
Total Expense Ratio1.410.89158%
Annual Report Gross Expense Ratio1.930.89217%
Fund Existence21 years23 years-
Gain YTD10.86214.36476%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets103M266B0%
Annual Yield % from dividends2.191.49148%
Returns for 1 year14.108.34169%
Returns for 3 years48.0849.2698%
Returns for 5 years59.9540.24149%
Returns for 10 years63.3172.1888%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN24.211.20
+5.22%
Viridian Therapeutics
ACI19.740.51
+2.65%
Albertsons Companies
PRFX1.24N/A
-0.40%
PainReform Ltd
BOC13.76-0.10
-0.72%
Boston Omaha Corp
ASRT0.80-0.02
-2.90%
Assertio Holdings